Anthocyanin Induces Apoptosis of DU-145 CellsIn Vitroand Inhibits Xenograft Growth of Prostate Cancer
Male
0301 basic medicine
Cell Survival
Mice, Nude
Prostatic Neoplasms
Apoptosis
Prostate-Specific Antigen
NAD
Xenograft Model Antitumor Assays
3. Good health
Anthocyanins
Gene Expression Regulation, Neoplastic
Mice, Inbred C57BL
03 medical and health sciences
Receptors, Androgen
Cell Line, Tumor
Animals
Humans
Original Article
Tumor Suppressor Protein p53
Cell Proliferation
bcl-2-Associated X Protein
DOI:
10.3349/ymj.2015.56.1.16
Publication Date:
2014-12-15T08:33:25Z
AUTHORS (10)
ABSTRACT
To investigate the effects of anthocyanins extracted from black soybean, which have antioxidant activity, on apoptosis in vitro (in hormone refractory prostate cancer cells) and on tumor growth in vivo (in athymic nude mouse xenograft model).The growth and viability of DU-145 cells treated with anthocyanins were assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and apoptosis was assessed by DNA laddering. Immunoblotting was conducted to evaluate differences in the expressions of p53, Bax, Bcl, androgen receptor (AR), and prostate specific antigen (PSA). To study the inhibitory effects of anthocyanins on tumor growth in vivo, DU-145 tumor xenografts were established in athymic nude mice. The anthocyanin group was treated with daily oral anthocyanin (8 mg/kg) for 14 weeks. After 2 weeks of treatment, DU-145 cells (2×10⁶) were inoculated subcutaneously into the right flank to establish tumor xenografts. Tumor dimensions were measured twice a week using calipers and volumes were calculated.Anthocyanin treatment of DU-145 cells resulted in 1) significant increase in apoptosis in a dose-dependent manner, 2) significant decrease in p53 and Bcl-2 expressions (with increased Bax expression), and 3) significant decrease in PSA and AR expressions. In the xenograft model, anthocyanin treatment significantly inhibit tumor growth.This study suggests that anthocyanins from black soybean inhibit the progression of prostate cancer in vitro and in a xenograft model.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (42)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....